Sunshine Biopharma (SBFMW) Selling, General & Administrative Expenses

Annual SGA

$10.83 M
+$1.35 M+14.26%

December 31, 2023


Summary


Performance

SBFMW SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSBFMWexpensesmetrics:

Quarterly SGA

$3.73 M
+$733.42 K+24.52%

September 30, 2024


Summary


Performance

SBFMW Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSBFMWexpensesmetrics:

TTM SGA

-$261.66 M
-$4.23 M-1.64%

September 30, 2024


Summary


Performance

SBFMW TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSBFMWexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

SBFMW Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.3%+10.7%-2464.0%
3 y3 years+1685.2%+304.3%-10000.0%
5 y5 years-+1156.8%-10000.0%

SBFMW Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+480.4%-41.9%+1681.7%-115.1%at low
5 y5-yearat high+1685.2%-41.9%+1681.7%-289.7%at low
alltimeall timeat high+1685.2%-41.9%+1681.7%<-9999.0%at low

Sunshine Biopharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.73 M(+24.5%)
$12.90 M(+11.0%)
Jun 2024
-
$2.99 M(-11.1%)
$11.62 M(+5.0%)
Mar 2024
-
$3.36 M(+19.3%)
$11.07 M(+2.2%)
Dec 2023
$10.83 M(+14.3%)
$2.82 M(+15.5%)
$10.83 M(-24.9%)
Sep 2023
-
$2.44 M(-0.0%)
$14.42 M(+7.6%)
Jun 2023
-
$2.44 M(-21.9%)
$13.40 M(+14.7%)
Mar 2023
-
$3.13 M(-51.3%)
$11.68 M(+23.3%)
Dec 2022
$9.48 M
$6.41 M(+351.0%)
$9.48 M(+189.4%)
DateAnnualQuarterlyTTM
Sep 2022
-
$1.42 M(+96.6%)
$3.28 M(+52.0%)
Jun 2022
-
$723.19 K(-21.5%)
$2.16 M(+29.8%)
Mar 2022
-
$921.40 K(+340.7%)
$1.66 M(-11.0%)
Dec 2021
$1.87 M(+207.6%)
$209.08 K(-30.6%)
$1.87 M(-4.5%)
Sep 2021
-
$301.48 K(+32.2%)
$1.95 M(+18.3%)
Jun 2021
-
$228.00 K(-79.8%)
$1.65 M(+16.0%)
Mar 2021
-
$1.13 M(+280.3%)
$1.42 M(+380.3%)
Dec 2020
$606.64 K(-2.6%)
$296.38 K
$296.38 K
Dec 2019
$622.73 K
-
-

FAQ

  • What is Sunshine Biopharma annual SGA?
  • What is the all time high annual SGA for Sunshine Biopharma?
  • What is Sunshine Biopharma annual SGA year-on-year change?
  • What is Sunshine Biopharma quarterly SGA?
  • What is the all time high quarterly SGA for Sunshine Biopharma?
  • What is Sunshine Biopharma quarterly SGA year-on-year change?
  • What is Sunshine Biopharma TTM SGA?
  • What is the all time high TTM SGA for Sunshine Biopharma?
  • What is Sunshine Biopharma TTM SGA year-on-year change?

What is Sunshine Biopharma annual SGA?

The current annual SGA of SBFMW is $10.83 M

What is the all time high annual SGA for Sunshine Biopharma?

Sunshine Biopharma all-time high annual SGA is $10.83 M

What is Sunshine Biopharma annual SGA year-on-year change?

Over the past year, SBFMW annual SGA has changed by +$1.35 M (+14.26%)

What is Sunshine Biopharma quarterly SGA?

The current quarterly SGA of SBFMW is $3.73 M

What is the all time high quarterly SGA for Sunshine Biopharma?

Sunshine Biopharma all-time high quarterly SGA is $6.41 M

What is Sunshine Biopharma quarterly SGA year-on-year change?

Over the past year, SBFMW quarterly SGA has changed by +$360.67 K (+10.72%)

What is Sunshine Biopharma TTM SGA?

The current TTM SGA of SBFMW is -$261.66 M

What is the all time high TTM SGA for Sunshine Biopharma?

Sunshine Biopharma all-time high TTM SGA is -$21.91 K

What is Sunshine Biopharma TTM SGA year-on-year change?

Over the past year, SBFMW TTM SGA has changed by -$272.73 M (-2464.04%)